Shukra Pharmaceuticals Postal Ballot Approved with 99.99% Votes for Director Continuation
Shukra Pharmaceuticals Limited completed its postal ballot through remote e-voting with overwhelming shareholder approval for continuing Mr. Jitendra Somchand Shah as Non-Executive Independent Director beyond 75 years. The special resolution received 99.99% support with 9,808,776 votes in favor and only 1,108 against, out of total 9,809,884 votes cast. The e-voting process ran from December 04, 2025, to January 03, 2026, with results declared on January 05, 2026, under scrutinizer Mrs. Rupal Patel's supervision.

*this image is generated using AI for illustrative purposes only.
Shukra Pharmaceuticals Limited has successfully concluded its postal ballot process through remote e-voting, with shareholders providing overwhelming support for continuing the directorship of an independent director beyond the statutory age limit. The company announced the voting results on January 05, 2026, following the completion of the e-voting period.
Postal Ballot Resolution Details
The postal ballot focused on a single special resolution to approve the continuation of Mr. Jitendra Somchand Shah (DIN: 01609325) as Non-Executive Independent Director beyond the age of 75 years in his current tenure. The resolution was deemed necessary as per regulatory requirements for directors exceeding the standard age limit.
| Parameter | Details |
|---|---|
| Resolution Type | Special Resolution |
| Director Name | Mr. Jitendra Somchand Shah |
| DIN | 01609325 |
| Position | Non-Executive Independent Director |
| Purpose | Continuation beyond 75 years |
Voting Process and Timeline
The remote e-voting process was conducted exclusively through electronic means, in accordance with MCA circulars and SEBI regulations. The voting commenced on Thursday, December 04, 2025, at 09:00 AM (IST) and concluded on Saturday, January 03, 2026, at 05:00 PM (IST). National Securities Depository Limited (NSDL) provided the e-voting platform for the process.
| Timeline Details | Date/Information |
|---|---|
| Record Date | November 21, 2025 |
| Notice Date | November 29, 2025 |
| Dispatch Completion | December 03, 2025 |
| Voting Start | December 04, 2025, 09:00 AM |
| Voting End | January 03, 2026, 05:00 PM |
| Results Declaration | January 05, 2026 |
Overwhelming Shareholder Support
The voting results demonstrated strong shareholder confidence in the director's continuation. Out of 23,733 total shareholders on the record date, 50 members participated in the voting process. The resolution received exceptional support with 99.99% votes in favor.
| Voting Results | Numbers | Percentage |
|---|---|---|
| Total Votes Cast | 9,809,884 | 100.00% |
| Votes in Favor | 9,808,776 | 99.99% |
| Votes Against | 1,108 | 0.01% |
| Invalid Votes | 0 | 0.00% |
| Members Voted For | 48 | - |
| Members Voted Against | 2 | - |
Category-wise Voting Breakdown
The voting pattern showed strong support across different shareholder categories. Promoter and Promoter Group held 223,135,600 shares and cast 9,760,000 votes entirely in favor of the resolution. Public Non-Institutions category, holding 214,743,840 shares, cast 49,884 votes with 48,776 in favor and 1,108 against.
Regulatory Compliance and Scrutiny
Mrs. Rupal Patel, Practicing Company Secretary (C.P. No. 3803), served as the appointed scrutinizer for the postal ballot process. The scrutinizer's report confirmed the validity of the voting process and declared the resolution as passed with the requisite majority. The entire process was conducted in compliance with Section 108 and Section 110 of the Companies Act, 2013, and SEBI Listing Regulations.
The company has fulfilled all regulatory requirements by submitting the voting results to BSE Limited and uploading the details on its website for stakeholder transparency.
Historical Stock Returns for Shukra Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.69% | -15.98% | +24.05% | +172.32% | +186.26% | +20,641.67% |










































